[March 01, 2018] |
|
Patterson Companies Reports Fiscal 2018 Third-Quarter Results
Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net
sales of approximately $1.4 billion (see attached Sales Summary for
further details) in its fiscal third quarter ended January 27, 2018, a
decline of 1.6 percent compared to the same period last year. Adjusting
for the effects of currency translation, sales declined 2.7 percent.
Reported net income from continuing operations for the third quarter of
fiscal year 2018 was $109.0 million, or $1.18 per diluted share,
compared to $27.8 million, or $0.29 per diluted share, in last year's
fiscal third quarter. The current period includes the recognition of a
provisional net tax benefit of $77.3 million, reflecting the revaluation
of tax-deferred assets and liabilities, net of a one-time transition tax
on unremitted foreign earnings as a result of the Tax Cuts and Jobs Act
("2017 Tax Act") enacted during the third quarter.
Adjusted net income1 from continuing operations, which
excludes certain non-recurring items, deal amortization costs and the
provisional net tax benefit related to the 2017 Tax Act, totaled $39.6
million for the third quarter of fiscal 2018, down 28.6 percent from
$55.4 million in the same quarter last year, driven by decreased sales
and gross margin compression. Adjusted earnings1 per diluted
share from continuing operations totaled $0.43 in the third quarter,
down 25.9 percent year-over-year.
"Our third-quarter results did not meet our expectations," said Mark
Walchirk, president and CEO of Patterson Companies. "Since joining
Patterson 90 days ago, I have begun a thorough review of our business
and the factors impacting performance. We are moving quickly to
implement an initial set of actions to improve our results, focused on
enhancing the customer experience and driving better execution across
the business."
Walchirk continued, "We have much more work to do to position Patterson
to reach its full potential, but I am confident in the strength of our
end markets, our deep customer relationships and the broad value
proposition we offer. We are committed to continuing to take clear
actions to improve our execution and set the foundation to drive
improved performance and long-term value."
Patterson Dental Reported net sales in our Dental segment
for the third quarter, which represented approximately 42 percent of
total company sales, were $577.9 million, down 7.7 percent from the same
quarter last year. Sales declined 8.1 percent on a constant currency
basis compared to the fiscal 2017 third quarter. On that same basis,
year-over-year sales by category were as follows:
-
Consumable dental supplies decreased 7.4 percent.
-
Equipment sales declined 10.6 percent.
-
Other services and products, primarily composed of technical service,
parts and labor, software support services and office supplies
decreased 3.4 percent.
"Our Dental segment results reflect the impact of a number of
transitions taking place within our business, including changes in our
sales force, disruptions resulting from our enterprise resource planning
implementation and the expansion of our digital equipment portfolio,"
continued Walchirk. "As we work to improve execution and performance, we
are making meaningful progress increasing unit placements of our new
technology offerings, reinforcing this strategic decision."
Patterson Animal Health Reported net sales in our Animal
Health segment for the third quarter of fiscal 2018, which comprised
approximately 58 percent of the company's total sales, were $794.9
million, up 4.2 percent from last year's third quarter. After
normalizing for the impact of currency and changes in product selling
relationships, segment sales increased 4.6 percent from the fiscal 2017
third quarter. On that same basis, year-over-year sales by category were
as follows:
-
Global companion animal sales rose 0.4 percent.
-
Production animal sales increased 8.8 percent, reflecting particularly
strong performance across swine and beef cattle species.
"In our Animal Health segment, our production animal business drove
solid growth across species and channels and we continue to benefit from
positive end-market fundamentals," continued Walchirk. "The lower sales
growth rate in our companion animal business was primarily related to a
decrease in promotional activity compared to last year."
Share Repurchases and Dividends In the third quarter of
fiscal 2018, Patterson repurchased approximately 0.4 million shares of
its outstanding common stock, with a value of $13.5 million, leaving
approximately 11.5 million shares for repurchase under the current
authorization, which expires in March 2018. The company also paid $24.7
million in cash dividends to shareholders in the third quarter of fiscal
2018. For the first nine months of fiscal 2018, the company has returned
a total of $162 million to shareholders in the form of share repurchases
and dividends.
Year-to-Date Results1 Consolidated sales
for the first nine months of fiscal 2018 totaled $4.1 billion, a 2.0
percent year-over-year decrease. Reported net income from continuing
operations was $180.0 million, or $1.93 per diluted share, compared
to $112.4 million, or $1.17 per diluted share in last year's period.
This comparison includes the recognition of a provisional net tax
benefit of $77.3 million, reflecting the revaluation of tax-deferred
assets and liabilities, net of a one-time transition tax on unremitted
foreign earnings as a result of the 2017 Tax Act enacted during the
third quarter.
Adjusted net income1 from continuing operations, which
excludes certain non-recurring items, deal amortization costs and the
provisional net tax benefit related to the 2017 Tax Act, totaled $128.6
million, or $1.38 per diluted share, compared to adjusted net income
from continuing operations of $157.7 million, or $1.64 per diluted
share, in the year-ago period.
FY2018 Guidance Patterson today revised its fiscal 2018
earnings guidance from continuing operations, which is provided on both
a GAAP and non-GAAP adjusted1 basis:
-
GAAP earnings from continuing operations are now expected to be in the
range of $2.13 to $2.18 per diluted share.
-
Non-GAAP adjusted earnings1 from continuing operations for
fiscal 2018 are now expected to be in the range of $1.65 to $1.70 per
diluted share.
-
Our non-GAAP adjusted earnings1 guidance excludes the
after-tax impact of:
-
Deal amortization expense of approximately $26.9 million ($0.29
per diluted share);
-
Integration and business restructuring expenses of approximately
$5.7 million ($0.06 per diluted share);
-
Provisional net tax benefit related to the 2017 Tax Act of
approximately $77.3 million ($0.83 per diluted share).
Our guidance is for current continuing operations as well as completed
or previously announced acquisitions and does not include the impact of
potential future acquisitions or similar transactions, if any, or
impairments and material restructurings beyond those previously publicly
disclosed. Our guidance assumes North American and international market
conditions similar to those experienced in the first nine months of
fiscal 2018.
Patterson Announces CFO Transition Patterson also announced
that Ann Gugino, executive vice president and chief financial officer,
will transition from her role as CFO, effective March 1, 2018. Patterson
has appointed Dennis Goedken, current corporate controller, to serve as
interim CFO in addition to his current role, while the company conducts
a search for a permanent replacement. Ms. Gugino's departure is not
related to the company's financial condition, financial disclosure or
strategic direction, and Ms. Gugino has agreed to serve as a special
advisor to the company until July 31, 2018.
Said Walchirk, "We are grateful to Ann for her many contributions to
Patterson over the past 18 years with the company, and I thank her for
her support during my transition. On behalf of the entire Patterson
team, we wish her all the best. We are also fortunate to have someone
with Dennis' experience to serve as interim CFO while we conduct a
search for a finance executive to help execute our strategic priorities."
Mr. Goedken has spent more than 12 years with Patterson having served as
the corporate controller since 2012, and as Patterson's assistant
controller from 1991-1998. During his tenure, Mr. Goedken was integrally
involved in internal audit, taking the company public and various
divestitures and acquisitions. Mr. Goedken currently leads the
accounting team and oversees preparation of all SEC filings. Previously,
Mr. Goedken has held senior finance leadership positions with Ceridian
HCM, Inc. and Lifetouch Inc.
1Non-GAAP Financial Measures The
Reconciliation of GAAP to non-GAAP Measures table appearing behind the
accompanying financial information is provided to adjust reported GAAP
measures, namely earnings from continuing operations, net income from
continuing operations and earnings per diluted share from continuing
operations, for the impact of transaction related costs, deal
amortization expenses, intangible asset impairment, integration and
business restructuring expenses, along with the related tax effects of
these items, the impact of the 2017 Tax Act and other discrete tax
matters.
Management believes that these non-GAAP measures may provide a helpful
representation of the company's third-quarter and full-year performance,
and enable comparison of financial results between periods where certain
items may vary independent of business performance. These non-GAAP
financial measures are presented solely for informational and
comparative purposes and should not be regarded as a replacement for
corresponding, similarly captioned, GAAP measures.
In addition, the term constant currency used in this release represents
net sales adjusted to exclude foreign currency impacts. Foreign currency
impact represents the difference in results that is attributable to
fluctuations in currency exchange rates the company uses to convert
results for all foreign entities where the functional currency is not
the U.S. dollar. The company calculates the impact as the difference
between the current period results translated using the current period
currency exchange rates and using the comparable prior period's currency
exchange rates. The company believes the disclosure of net sales changes
in constant currency provides useful supplementary information to
investors in light of significant fluctuations in currency rates.
Third-Quarter Conference Call and Replay Patterson's
third-quarter earnings conference call will start at 10 a.m. Eastern
today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com.
The conference call will be archived on Patterson's website. A replay of
the fiscal 2018 third-quarter conference call can be heard for one week
at 800-585-8367 and by providing the Conference ID 6584419 when prompted.
About Patterson Companies, Inc. Patterson Companies, Inc. is
a value-added distributor serving the dental and animal health markets.
Dental Market Patterson's Dental
segment provides a virtually complete range of consumable dental
products, equipment and software, turnkey digital solutions and
value-added services to dentists and dental laboratories throughout
North America.
Animal Health Market Patterson's
Animal Health segment is a leading distributor of products, services and
technologies to both the production and companion animal health markets
in North America and the U.K.
This press release contains certain forward-looking statements, as
defined in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are information of a non-historical nature
and are subject to risks and uncertainties that are beyond Patterson's
ability to control. Forward-looking statements generally can be
identified by words such as "believes," "expects," "anticipates,"
"foresees," "forecasts," "estimates" or other words or phrases of
similar import. It is uncertain whether any of the events anticipated by
the forward-looking statements will transpire or occur, or if any of
them do, what impact they will have on the results of operations and
financial condition of Patterson or the price of Patterson stock. These
forward-looking statements involve certain risks and uncertainties that
could cause actual results to differ materially from those indicated in
such forward-looking statements. Such risks and uncertainties include,
without limitation, operations disruptions attributable to our
enterprise resource planning system implementation; our ability to
attract or retain qualified sales representatives and service
technicians who relate directly with our customers; the reduction,
modification, cancellation or delay of purchases of innovative,
high-margin equipment; material changes in our purchasing relationships
with suppliers; changes in general market and economic conditions; and
the other risks and important factors contained and identified in
Patterson's filings with the Securities and Exchange Commission, such as
its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any
of which could cause actual results to differ materially from the
forward-looking statements. Any forward-looking statement in this press
release speaks only as of the date on which it is made. Except to the
extent required under the federal securities laws, Patterson does not
intend to update or revise the forward-looking statements.
|
PATTERSON COMPANIES, INC.
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
|
(In thousands, except per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
January 27,
|
|
|
January 28,
|
|
|
January 27,
|
|
|
January 28,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
1,375,222
|
|
|
|
$
|
1,397,418
|
|
|
|
$
|
4,065,074
|
|
|
|
$
|
4,148,095
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
294,736
|
|
|
|
|
329,761
|
|
|
|
|
909,527
|
|
|
|
|
965,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
244,690
|
|
|
|
|
283,207
|
|
|
|
|
730,889
|
|
|
|
|
774,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations
|
|
|
|
50,046
|
|
|
|
|
46,554
|
|
|
|
|
178,638
|
|
|
|
|
191,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income, net
|
|
|
|
2,096
|
|
|
|
|
994
|
|
|
|
|
4,768
|
|
|
|
|
4,980
|
|
Interest expense
|
|
|
|
(11,783
|
)
|
|
|
|
(11,400
|
)
|
|
|
|
(34,454
|
)
|
|
|
|
(31,659
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes
|
|
|
|
40,359
|
|
|
|
|
36,148
|
|
|
|
|
148,952
|
|
|
|
|
165,094
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit)
|
|
|
|
(68,596
|
)
|
|
|
|
8,379
|
|
|
|
|
(31,094
|
)
|
|
|
|
52,663
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
|
|
108,955
|
|
|
|
|
27,769
|
|
|
|
|
180,046
|
|
|
|
|
112,431
|
|
Net loss from discontinued operations
|
|
|
|
-
|
|
|
|
|
(3,229
|
)
|
|
|
|
-
|
|
|
|
|
(3,229
|
)
|
Net income
|
|
|
$
|
108,955
|
|
|
|
$
|
24,540
|
|
|
|
$
|
180,046
|
|
|
|
$
|
109,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
$
|
1.18
|
|
|
|
$
|
0.29
|
|
|
|
$
|
1.94
|
|
|
|
$
|
1.18
|
|
Discontinued operations
|
|
|
|
-
|
|
|
|
|
(0.03
|
)
|
|
|
|
-
|
|
|
|
|
(0.03
|
)
|
Net basic earnings per share
|
|
|
$
|
1.18
|
|
|
|
$
|
0.26
|
|
|
|
$
|
1.94
|
|
|
|
$
|
1.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
$
|
1.18
|
|
|
|
$
|
0.29
|
|
|
|
$
|
1.93
|
|
|
|
$
|
1.17
|
|
Discontinued operations
|
|
|
|
-
|
|
|
|
|
(0.03
|
)
|
|
|
|
-
|
|
|
|
|
(0.03
|
)
|
Net diluted earnings per share
|
|
|
$
|
1.18
|
|
|
|
$
|
0.26
|
|
|
|
$
|
1.93
|
|
|
|
$
|
1.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
91,949
|
|
|
|
|
94,737
|
|
|
|
|
92,674
|
|
|
|
|
95,252
|
|
Diluted
|
|
|
|
92,609
|
|
|
|
|
95,359
|
|
|
|
|
93,323
|
|
|
|
|
95,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
|
$
|
0.26
|
|
|
|
$
|
0.24
|
|
|
|
$
|
0.78
|
|
|
|
$
|
0.72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PATTERSON COMPANIES, INC.
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
January 27,
|
|
|
April 29,
|
|
|
|
2018
|
|
|
2017
|
|
|
|
(Unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
118,005
|
|
|
$
|
94,959
|
Receivables
|
|
|
|
863,455
|
|
|
|
884,803
|
Inventory
|
|
|
|
882,018
|
|
|
|
711,903
|
Prepaid expenses and other current assets
|
|
|
|
116,310
|
|
|
|
111,928
|
Total current assets
|
|
|
|
1,979,788
|
|
|
|
1,803,593
|
Property and equipment, net
|
|
|
|
287,439
|
|
|
|
298,452
|
Goodwill and other intangible assets
|
|
|
|
1,216,374
|
|
|
|
1,238,983
|
Long-term receivables, net and other
|
|
|
|
190,757
|
|
|
|
166,885
|
Total assets
|
|
|
$
|
3,674,358
|
|
|
$
|
3,507,913
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
654,792
|
|
|
$
|
616,859
|
Other accrued liabilities
|
|
|
|
191,540
|
|
|
|
213,318
|
Current maturities of long-term debt
|
|
|
|
74,754
|
|
|
|
14,754
|
Borrowings on revolving credit
|
|
|
|
179,000
|
|
|
|
59,000
|
Total current liabilities
|
|
|
|
1,100,086
|
|
|
|
903,931
|
Long-term debt
|
|
|
|
931,419
|
|
|
|
998,272
|
Other non-current liabilities
|
|
|
|
179,863
|
|
|
|
211,277
|
Total liabilities
|
|
|
|
2,211,368
|
|
|
|
2,113,480
|
Stockholders' equity
|
|
|
|
1,462,990
|
|
|
|
1,394,433
|
Total liabilities and stockholders' equity
|
|
|
$
|
3,674,358
|
|
|
$
|
3,507,913
|
|
|
|
|
|
|
|
|
PATTERSON COMPANIES, INC.
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
January 27,
|
|
|
January 28,
|
|
|
|
2018
|
|
|
2017
|
|
|
|
|
|
|
|
Operating activities:
|
|
|
|
|
|
|
Net income
|
|
|
$
|
180,046
|
|
|
|
$
|
109,202
|
|
Net loss from discontinued operations
|
|
|
|
-
|
|
|
|
|
(3,229
|
)
|
Net income from continuing operations
|
|
|
|
180,046
|
|
|
|
|
112,431
|
|
Adjustments to reconcile net income from continuing operations to
net cash provided by (used in) operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
62,787
|
|
|
|
|
63,056
|
|
Intangible asset impairment
|
|
|
|
-
|
|
|
|
|
36,312
|
|
Non-cash employee compensation
|
|
|
|
22,999
|
|
|
|
|
17,254
|
|
Change in assets and liabilities, net of acquired
|
|
|
|
(225,819
|
)
|
|
|
|
(238,464
|
)
|
Net cash provided by (used in) operating activities- continuing
operations
|
|
|
|
40,013
|
|
|
|
|
(9,411
|
)
|
Net cash used in operating activities- discontinued operations
|
|
|
|
-
|
|
|
|
|
(3,229
|
)
|
Net cash provided by (used in) operating activities
|
|
|
|
40,013
|
|
|
|
|
(12,640
|
)
|
Investing activities:
|
|
|
|
|
|
|
Additions to property and equipment
|
|
|
|
(28,239
|
)
|
|
|
|
(37,457
|
)
|
Collection of deferred purchase price receivables
|
|
|
|
37,068
|
|
|
|
|
38,964
|
|
Other investing activities
|
|
|
|
10,600
|
|
|
|
|
(3,095
|
)
|
Net cash provided by (used in) investing activities- continuing
operations
|
|
|
|
19,429
|
|
|
|
|
(1,588
|
)
|
Net cash provided by investing activities- discontinued operations
|
|
|
|
-
|
|
|
|
|
-
|
|
Net cash provided by (used in) investing activities
|
|
|
|
19,429
|
|
|
|
|
(1,588
|
)
|
Financing activities:
|
|
|
|
|
|
|
Dividends paid
|
|
|
|
(74,641
|
)
|
|
|
|
(70,947
|
)
|
Repurchases of common stock
|
|
|
|
(87,500
|
)
|
|
|
|
(84,651
|
)
|
Debt amendment costs
|
|
|
|
-
|
|
|
|
|
(1,266
|
)
|
Retirement of long-term debt
|
|
|
|
(7,377
|
)
|
|
|
|
(22,550
|
)
|
Draw on revolver
|
|
|
|
120,000
|
|
|
|
|
178,000
|
|
Other financing activities
|
|
|
|
7,546
|
|
|
|
|
5,495
|
|
Net cash provided by (used in) financing activities
|
|
|
|
(41,972
|
)
|
|
|
|
4,081
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
|
5,576
|
|
|
|
|
(5,567
|
)
|
Net change in cash and cash equivalents
|
|
|
$
|
23,046
|
|
|
|
$
|
(15,714
|
)
|
|
|
|
|
|
|
|
|
PATTERSON COMPANIES, INC.
|
SALES SUMMARY
|
(Dollars in thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
Foreign
|
|
|
|
|
|
|
January 27,
|
|
|
January 28,
|
|
|
Sales
|
|
|
Exchange
|
|
|
Internal
|
|
|
|
2018
|
|
|
2017
|
|
|
Growth
|
|
|
Impact
|
|
|
Growth
|
Three Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
1,074,189
|
|
|
$
|
1,064,098
|
|
|
0.9
|
%
|
|
|
1.3
|
%
|
|
|
(0.4
|
)%
|
Equipment and software
|
|
|
|
222,574
|
|
|
|
249,047
|
|
|
(10.6
|
)
|
|
|
0.4
|
|
|
|
(11.0
|
)
|
Other
|
|
|
|
78,459
|
|
|
|
84,273
|
|
|
(6.9
|
)
|
|
|
0.6
|
|
|
|
(7.5
|
)
|
Total
|
|
|
$
|
1,375,222
|
|
|
$
|
1,397,418
|
|
|
(1.6
|
)%
|
|
|
1.1
|
%
|
|
|
(2.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dental
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
302,296
|
|
|
$
|
325,181
|
|
|
(7.0
|
)%
|
|
|
0.4
|
%
|
|
|
(7.4
|
)%
|
Equipment and software
|
|
|
|
207,000
|
|
|
|
230,431
|
|
|
(10.2
|
)
|
|
|
0.4
|
|
|
|
(10.6
|
)
|
Other
|
|
|
|
68,581
|
|
|
|
70,731
|
|
|
(3.0
|
)
|
|
|
0.4
|
|
|
|
(3.4
|
)
|
Total
|
|
|
$
|
577,877
|
|
|
$
|
626,343
|
|
|
(7.7
|
)%
|
|
|
0.4
|
%
|
|
|
(8.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Animal Health
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
771,893
|
|
|
$
|
738,917
|
|
|
4.5
|
%
|
|
|
1.6
|
%
|
|
|
2.9
|
%
|
Equipment and software
|
|
|
|
15,574
|
|
|
|
18,616
|
|
|
(16.3
|
)
|
|
|
0.1
|
|
|
|
(16.4
|
)
|
Other
|
|
|
|
7,400
|
|
|
|
5,044
|
|
|
46.7
|
|
|
|
5.9
|
|
|
|
40.8
|
|
Total
|
|
|
$
|
794,867
|
|
|
$
|
762,577
|
|
|
4.2
|
%
|
|
|
1.6
|
%
|
|
|
2.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
$
|
2,478
|
|
|
$
|
8,498
|
|
|
(70.8
|
)%
|
|
|
-
|
%
|
|
|
(70.8
|
)%
|
Total
|
|
|
$
|
2,478
|
|
|
$
|
8,498
|
|
|
(70.8
|
)%
|
|
|
-
|
%
|
|
|
(70.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
3,270,385
|
|
|
$
|
3,252,551
|
|
|
0.5
|
%
|
|
|
0.2
|
%
|
|
|
0.3
|
%
|
Equipment and software
|
|
|
|
540,860
|
|
|
|
627,187
|
|
|
(13.8
|
)
|
|
|
0.2
|
|
|
|
(14.0
|
)
|
Other
|
|
|
|
253,829
|
|
|
|
268,357
|
|
|
(5.4
|
)
|
|
|
0.1
|
|
|
|
(5.5
|
)
|
Total
|
|
|
$
|
4,065,074
|
|
|
$
|
4,148,095
|
|
|
(2.0
|
)%
|
|
|
0.2
|
%
|
|
|
(2.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dental
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
933,691
|
|
|
$
|
982,366
|
|
|
(5.0
|
)%
|
|
|
0.2
|
%
|
|
|
(5.2
|
)%
|
Equipment and software
|
|
|
|
504,376
|
|
|
|
586,375
|
|
|
(14.0
|
)
|
|
|
0.2
|
|
|
|
(14.2
|
)
|
Other
|
|
|
|
212,247
|
|
|
|
214,170
|
|
|
(0.9
|
)
|
|
|
0.2
|
|
|
|
(1.1
|
)
|
Total
|
|
|
$
|
1,650,314
|
|
|
$
|
1,782,911
|
|
|
(7.4
|
)%
|
|
|
0.2
|
%
|
|
|
(7.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Animal Health
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumable
|
|
|
$
|
2,336,694
|
|
|
$
|
2,270,185
|
|
|
2.9
|
%
|
|
|
0.2
|
%
|
|
|
2.7
|
%
|
Equipment and software
|
|
|
|
36,484
|
|
|
|
40,812
|
|
|
(10.6
|
)
|
|
|
-
|
|
|
|
(10.6
|
)
|
Other
|
|
|
|
21,408
|
|
|
|
21,357
|
|
|
0.2
|
|
|
|
-
|
|
|
|
0.2
|
|
Total
|
|
|
$
|
2,394,586
|
|
|
$
|
2,332,354
|
|
|
2.7
|
%
|
|
|
0.2
|
%
|
|
|
2.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
$
|
20,174
|
|
|
$
|
32,830
|
|
|
(38.6
|
)%
|
|
|
-
|
%
|
|
|
(38.6
|
)%
|
Total
|
|
|
$
|
20,174
|
|
|
$
|
32,830
|
|
|
(38.6
|
)%
|
|
|
-
|
%
|
|
|
(38.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PATTERSON COMPANIES, INC.
|
OPERATING INCOME BY SEGMENT
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
January 27,
|
|
|
January 28,
|
|
|
January 27,
|
|
|
January 28,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
Dental
|
|
|
$
|
58,439
|
|
|
|
$
|
40,018
|
|
|
|
$
|
183,165
|
|
|
|
$
|
177,356
|
|
Animal Health
|
|
|
|
18,037
|
|
|
|
|
23,777
|
|
|
|
|
57,930
|
|
|
|
|
60,460
|
|
Corporate
|
|
|
|
(26,430
|
)
|
|
|
|
(17,241
|
)
|
|
|
|
(62,457
|
)
|
|
|
|
(46,043
|
)
|
Total
|
|
|
$
|
50,046
|
|
|
|
$
|
46,554
|
|
|
|
$
|
178,638
|
|
|
|
$
|
191,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PATTERSON COMPANIES, INC.
|
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
|
(Dollars in thousands, except per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Integration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
and business
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-
|
|
|
Deal
|
|
|
asset
|
|
|
restructuring
|
|
|
Discrete tax
|
|
|
|
For the three months ended January 27, 2018
|
|
|
GAAP
|
|
|
related costs
|
|
|
amortization
|
|
|
impairment
|
|
|
expenses
|
|
|
matters
|
|
|
Non-GAAP
|
Operating income from continuing operations
|
|
|
$
|
50,046
|
|
|
|
$
|
-
|
|
|
$
|
9,692
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
$
|
-
|
|
|
|
$
|
59,738
|
|
Other expense, net
|
|
|
|
(9,687
|
)
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(9,687
|
)
|
Income from continuing operations before taxes
|
|
|
|
40,359
|
|
|
|
|
-
|
|
|
|
9,692
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
50,051
|
|
Income tax expense (benefit)
|
|
|
|
(68,596
|
)
|
|
|
|
-
|
|
|
|
2,209
|
|
|
|
-
|
|
|
|
(370
|
)
|
|
|
|
77,256
|
|
|
|
|
10,499
|
|
Net income from continuing operations
|
|
|
$
|
108,955
|
|
|
|
$
|
-
|
|
|
$
|
7,483
|
|
|
$
|
-
|
|
|
$
|
370
|
|
|
|
$
|
(77,256
|
)
|
|
|
$
|
39,552
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations*
|
|
|
$
|
1.18
|
|
|
|
$
|
-
|
|
|
$
|
0.08
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
$
|
(0.83
|
)
|
|
|
$
|
0.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations as a % of sales
|
|
|
|
3.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.3
|
%
|
Effective tax rate
|
|
|
|
-170.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Integration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
and business
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-
|
|
|
Deal
|
|
|
asset
|
|
|
restructuring
|
|
|
Discrete tax
|
|
|
|
For the three months ended January 28, 2017
|
|
|
GAAP
|
|
|
related costs
|
|
|
amortization
|
|
|
impairment
|
|
|
expenses
|
|
|
matters
|
|
|
Non-GAAP
|
Operating income from continuing operations
|
|
|
$
|
46,554
|
|
|
|
$
|
236
|
|
|
$
|
9,951
|
|
|
$
|
36,312
|
|
|
$
|
625
|
|
|
|
$
|
-
|
|
|
|
$
|
93,678
|
|
Other expense, net
|
|
|
|
(10,406
|
)
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(10,406
|
)
|
Income from continuing operations before taxes
|
|
|
|
36,148
|
|
|
|
|
236
|
|
|
|
9,951
|
|
|
|
36,312
|
|
|
|
625
|
|
|
|
|
-
|
|
|
|
|
83,272
|
|
Income tax expense (benefit)
|
|
|
|
8,379
|
|
|
|
|
89
|
|
|
|
3,480
|
|
|
|
13,263
|
|
|
|
236
|
|
|
|
|
2,406
|
|
|
|
|
27,853
|
|
Net income from continuing operations
|
|
|
$
|
27,769
|
|
|
|
$
|
147
|
|
|
$
|
6,471
|
|
|
$
|
23,049
|
|
|
$
|
389
|
|
|
|
$
|
(2,406
|
)
|
|
|
$
|
55,419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations*
|
|
|
$
|
0.29
|
|
|
|
$
|
-
|
|
|
$
|
0.07
|
|
|
$
|
0.24
|
|
|
$
|
-
|
|
|
|
$
|
(0.03
|
)
|
|
|
$
|
0.58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations as a % of sales
|
|
|
|
3.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.7
|
%
|
Effective tax rate
|
|
|
|
23.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Integration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
and business
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-
|
|
|
Deal
|
|
|
asset
|
|
|
restructuring
|
|
|
Discrete tax
|
|
|
|
For the nine months ended January 27, 2018
|
|
|
GAAP
|
|
|
related costs
|
|
|
amortization
|
|
|
impairment
|
|
|
expenses
|
|
|
matters
|
|
|
Non-GAAP
|
Operating income from continuing operations
|
|
|
$
|
178,638
|
|
|
|
$
|
-
|
|
|
$
|
28,982
|
|
|
$
|
-
|
|
|
$
|
8,594
|
|
|
|
$
|
-
|
|
|
|
$
|
216,214
|
|
Other expense, net
|
|
|
|
(29,686
|
)
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(29,686
|
)
|
Income from continuing operations before taxes
|
|
|
|
148,952
|
|
|
|
|
-
|
|
|
|
28,982
|
|
|
|
-
|
|
|
|
8,594
|
|
|
|
|
-
|
|
|
|
|
186,528
|
|
Income tax expense (benefit)
|
|
|
|
(31,094
|
)
|
|
|
|
-
|
|
|
|
8,900
|
|
|
|
-
|
|
|
|
2,879
|
|
|
|
|
77,256
|
|
|
|
|
57,941
|
|
Net income from continuing operations
|
|
|
$
|
180,046
|
|
|
|
$
|
-
|
|
|
$
|
20,082
|
|
|
$
|
-
|
|
|
$
|
5,715
|
|
|
|
$
|
(77,256
|
)
|
|
|
$
|
128,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations*
|
|
|
$
|
1.93
|
|
|
|
$
|
-
|
|
|
$
|
0.22
|
|
|
$
|
-
|
|
|
$
|
0.06
|
|
|
|
$
|
(0.83
|
)
|
|
|
$
|
1.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations as a % of sales
|
|
|
|
4.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.3
|
%
|
Effective tax rate
|
|
|
|
-20.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Integration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
and business
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction-
|
|
|
Deal
|
|
|
asset
|
|
|
restructuring
|
|
|
Discrete tax
|
|
|
|
For the nine months ended January 28, 2017
|
|
|
GAAP
|
|
|
related costs
|
|
|
amortization
|
|
|
impairment
|
|
|
expenses
|
|
|
matters
|
|
|
Non-GAAP
|
Operating income from continuing operations
|
|
|
$
|
191,773
|
|
|
|
$
|
1,479
|
|
|
$
|
30,212
|
|
|
$
|
36,312
|
|
|
$
|
6,304
|
|
|
|
$
|
-
|
|
|
|
$
|
266,080
|
|
Other expense, net
|
|
|
|
(26,679
|
)
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(26,679
|
)
|
Income from continuing operations before taxes
|
|
|
|
165,094
|
|
|
|
|
1,479
|
|
|
|
30,212
|
|
|
|
36,312
|
|
|
|
6,304
|
|
|
|
|
-
|
|
|
|
|
239,401
|
|
Income tax expense (benefit)
|
|
|
|
52,663
|
|
|
|
|
558
|
|
|
|
10,394
|
|
|
|
13,263
|
|
|
|
2,383
|
|
|
|
|
2,406
|
|
|
|
|
81,667
|
|
Net income from continuing operations
|
|
|
$
|
112,431
|
|
|
|
$
|
921
|
|
|
$
|
19,818
|
|
|
$
|
23,049
|
|
|
$
|
3,921
|
|
|
|
$
|
(2,406
|
)
|
|
|
$
|
157,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations*
|
|
|
$
|
1.17
|
|
|
|
$
|
0.01
|
|
|
$
|
0.21
|
|
|
$
|
0.24
|
|
|
$
|
0.04
|
|
|
|
$
|
(0.03
|
)
|
|
|
$
|
1.64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations as a % of sales
|
|
|
|
4.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.4
|
%
|
Effective tax rate
|
|
|
|
31.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* May not sum due to rounding
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20180301005318/en/
[ Back To TMCnet.com's Homepage ]
|